Cellular therapy tools that have achieved groundbreaking advances in cancer treatment also could be applied to patients with HIV, according to Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy and the director of the Center for Immunotherapy at the University of Pennsylvania, in Philadelphia.
“We have a toolbox that is incredible for modifying in genetic ways both T cells and stem cells,” he said, “and for giving people what I call an